Hospices Civils de Lyon: Communicable Diseases trials

The registry lists 53 Communicable Diseases studies with Hospices Civils de Lyon as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 2Phase 4 2No phase 49(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort StudyRecruitingNCT06425250
• PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.RecruitingNCT06185920
• Phage Safety Retrospective Cohort StudyRecruitingNCT04724603
• Phage Safety Cohort StudyRecruitingNCT04650607
• Management and Outcome of Mesh Infection After Abdominoplasty in a Tertiary Care CentreCompletedNCT06682091
• Diagnostic and Management of Hand Infection.Active, not recruitingNCT06630988
• Complications in Pediatric Mechanical Circulatory Assistance: Evaluation of Infection Management.Active, not recruitingNCT05983341
• Evaluation of a Clinical Decision Support System for Fungal InfectionsCompletedNCT05656157
• The Contributions of the Multidisciplinary Management of Prosthesis Knee Infections in a Reference Center: A Retrospective Study About 52 Cases.Skin Coverage in a Reference Center: A Retrospective Study About 52 CasesStatus unknownNCT05367726
• Severity of RSV Infections in TwinsCompletedNCT05070975
• Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint InfectionsStatus unknownNCT04933344
• Recurrent S. Aureus Infections in Osteoarticular InfectionsStatus unknownNCT04712123
• Prospective Study of Patients Treated for Bone and Joint Infection (BJI) Due to Staphylococcus Aureus, Aiming at Identifying Biomarkers of Diagnosis Interest in Chronic BJITerminatedNCT04583241
• Postoperative Surgical Site Infection afterENT Bone Flap SurgeryCompletedNCT04492826
• Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) InfectionStatus unknownNCT04413838Phase 2
• Staphylococcus Lugdunensis Prosthetic Joint InfectionCompletedNCT04409392
• Host-pathogen Interactions During SARS-CoV-2 InfectionCompletedNCT04376476Not applicable
• Infection After Free Fibula Flap Reconstruction of the Mandible: a Retrospective Cohort StudyCompletedNCT04373278
• Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life Hospital EnvironmentWithdrawnNCT04226001
• Predictors of Respiratory Syncytial Virus (RSV) Hospitalizations in InfantsStatus unknownNCT04144816
• Perception of Smell and Taste During Antibiotic TreatmentCompletedNCT03893279
• Osteoarticular Infections With PneumococcalCompletedNCT03852784
• Comparison of Two Empirical Antimicrobial Therapies of Prosthetic Joint InfectionCompletedNCT03850860
• Chronic Infections on Articular Prostheses With C. Acnes Diagnosed by Specific PCRCompletedNCT03850548
• Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint InfectionsCompletedNCT03848104
• Prosthesis Infection and One-step Exchange: Pretreatment by Targeted Antibiotic Therapy in At-risk PatientsCompletedNCT03848091
• Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint InfectionCompletedNCT03808285
• Necrotizing External Otitis : Study in a Regional Bone and Joint Infection Reference CenterCompletedNCT03768635
• Staphylococcal Acute Post-Operative PJI Treated With 'DAIR' And Impact Of RifampinCompletedNCT03750721
• Stool Biobanking and Impact of Antimicrobials on the Gut Microbiota in Patients With Bone and Joint InfectionTerminatedNCT03633188Not applicable
• Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint InfectionCompletedNCT03627000
• Implant-Associated P. Aeruginosa Bone And Joint Infections : Experience In A Regional Reference Center In FranceCompletedNCT03624855
• Cost Of Failure Following Reimplantation After a 2-Stage Exchange Strategy For Hip Or Knee Prosthetic Joint InfectionCompletedNCT03612076
• Consitution Of A Biological Collection From Samples From The Gut Microbiote In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With BetalactamineStatus unknownNCT03611634
• Effectiveness and Safety of Antibiotherapy in Diabetic Patients Treated for a Diabetic Foot Infection.CompletedNCT03495349
• One-stage Exchange Arthroplasty for Chronic Prosthetic Joint InfectionsCompletedNCT03473392
• Subcutaneous Suppressive Antibiotic Therapy for Bone and Joint InfectionsCompletedNCT03403608
• Cost of Off-label Antibiotics in Osteoarticular InfectionsTerminatedNCT03335592
• Adherence to Oral Antibiotics In Patients With Osteoarticular InfectionsCompletedNCT03311113
• Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference CenterCompletedNCT03209934
• Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint InfectionsCompletedNCT03209921
• Bacterial Epidemiology and Empirical Antibiotherapy in Patients With Prosthetic Joint InfectionCompletedNCT03191292
• Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous AdministrationCompletedNCT03177369
• Pristinamycin in the Treatment of MSSA Bone and Joint InfectionCompletedNCT03177343
• Population Pharmacokinetic Analysis of Daptomycin in Patients With Osteoarticular InfectionsStatus unknownNCT03134521
• The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical MaterialsStatus unknownNCT03112356Phase 4
• Corynebacterium Spp Bone and Joint Infection: Retrospective Study of Microbiological, Diagnostic and Therapeutic FeaturesCompletedNCT03081273
• Pressure Ulcer-associated Osteomyelitis: Evaluation of a Two-stage Surgical Strategy With Prolonged Antimicrobial TherapyCompletedNCT03010293
• Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in ChildrenWithdrawnNCT02899702Phase 4
• Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis.CompletedNCT02847156Not applicable
• S. Aureus, Skin and Soft Tissue InfectionsCompletedNCT02796742
• Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral NutritionStatus unknownNCT02255318Not applicable
• Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A InfectionTerminatedNCT00830323Phase 2